Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TXG · against 596 other Healthcare companies listed in US-listed
Ranked #312 of 597 · scores higher than 48% of peers · safety percentile 40
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)30 peers with a safety percentile of 40–49, including TXG · Click a bar to see the companies
A mix: stronger current ratio and debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TXG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.10× | 0.23× | 64% | 33% | |
| BetaLower is better · 556 reported | 2.08 | 0.95 | 9% | 33% | |
| Current ratioHigher is better · 600 reported | 5.69× | 3.91× | 62% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 308 | 34M USD | 42 | 19 | |
| 309 | 9.0B USD | 41 | 57 | |
| 310 | 3.9B USD | 41 | 58 | |
| 311 | 1.6B USD | 41 | 51 | |
| 312 | 8.5B USD | 40 | 28 | |
| 313 | 915M USD | 40 | 57 | |
| 314 | 271M USD | 40 | 14 | |
| 315 | 4.3B USD | 40 | 54 | |
| 316 | 241M USD | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score